Search Results - "Mir, G. Nabi"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Alpha-2 receptors in the gastrointestinal system: a new therapeutic approach by DiJoseph, J F, Taylor, J A, Mir, G N

    Published in Life sciences (1973) (03-09-1984)
    “…Alpha-2 receptor activation mediates the inhibition of a number of gastrointestinal functions including gastric and intestinal secretions. Alpha-2 receptors…”
    Get more information
    Journal Article
  2. 2

    Gastric antisecretory and antiulcer effects of WHR1582A, a compound exerting alpha-2 adrenoceptor agonist activity by DiJoseph, J F, Eash, J R, Mir, G N

    “…The gastric antisecretory and antiulcer effects of a novel compound, [1-(2,-dimethylphenyl)-3-isobutoxyamidinourea]hydrochloride (WHR1582A), are described…”
    Get more information
    Journal Article
  3. 3

    N-Phenyl-2-pyridinecarbothioamides as gastric mucosal protectants by Kinney, William A, Lee, Nancy E, Blank, Robert M, Demerson, Christopher A, Sarnella, Carol S, Scherer, Noreen T, Mir, G. Nabi, Borella, Luis E, DiJoseph, John F, Wells, Cheryl

    Published in Journal of medicinal chemistry (01-01-1990)
    “…A series of substituted 2-pyridinecarbothioamides was synthesized and evaluated for gastric mucosal protectant activity in the rat. Out of this investigation…”
    Get full text
    Journal Article
  4. 4

    1',1'-Dimethylheptyl-delta-8-tetrahydrocannabinol-11-oic acid: a novel, orally effective cannabinoid with analgesic and anti-inflammatory properties by Dajani, E Z, Larsen, K R, Taylor, J, Dajani, N E, Shahwan, T G, Neeleman, S D, Taylor, M S, Dayton, M T, Mir, G N

    “…1',1'-Dimethylheptyl-Delta-8-tetrahydrocannabinol-11-oic acid (CT-3) is a novel cannabinoid that is under development by Atlantic Pharmaceuticals as an…”
    Get more information
    Journal Article
  5. 5

    Cytoprotective and antiulcer activities of the antacid magaldrate in the rat by Borella, L E, DiJoseph, J F, Mir, G N

    Published in Arzneimittel-Forschung (01-07-1989)
    “…The cytoprotective and antiulcer activities of the antacid magaldrate (ES Riopan) as well as its effects on gastric mucosal blood flow and mucus secretions,…”
    Get more information
    Journal Article
  6. 6

    N-phenyl-2-pyridine carbothioamides as gastric mucosal protectants by Kinney, WA, Lee, N E, Blank, R M, Demerson, CA, Sarnella, C S, Scherer, N T, Nabi Mir, G, Borella, LE, DiJoseph, J F, Wells, C

    Published in Journal of medicinal chemistry (01-01-1990)
    “…A series of substituted 2-pyridine carbothioamides was synthesized and evaluated for gastric mucosal protectant activity in the rat…”
    Get full text
    Journal Article
  7. 7

    Mucosal protective activity of activated aluminum complex by DiJoseph, J F, Borella, L E, Wells, C L, Mir, G N

    Published in Digestion (1990)
    “…The antacid ES Riopan was acidified ex vivo to pH 2.5 to completely eliminate its buffering capacity and was then tested as a mucosal protective agent. The pH…”
    Get more information
    Journal Article
  8. 8

    A semichronic diarrheal model by Mir, G N, Alioto, R L

    Published in Journal of pharmacological methods (01-03-1982)
    “…A method of producing semichronic diarrhea is presented. It has been shown that, when fed a combination diet of 50% lactose and 50% commercially available…”
    Get more information
    Journal Article